WALTHAM, Mass., May 01, 2018 -- NeuroMetrix, Inc. (Nasdaq:NURO), announced today that it will be participating in the 3rd annual Disruptive Growth & Healthcare Conference in New York City on May 8-9, 2018 sponsored by RHK Capital and ReedSmith. The conference offers an opportunity to discover life science companies focusing on unmet medical needs with disruptive technologies and business models. Those interested in attending the conference should visit http://disruptnyc.com/ for more information.
Shai Gozani, M.D., Ph.D., President and CEO of NeuroMetrix, Inc. will participate in a Pain Management Panel Discussion at 3:00 PM EDT on May 8. At 4:40 PM EDT on May 8 Dr. Gozani will present a business update and commentary on Quell®, the company’s a wearable device for management of chronic pain. A live webcast of the 4:40 PM EDT presentation will be available on NeuroMetrix’ investor relations page.
About NeuroMetrix
NeuroMetrix is an innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell®, an over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more
information, please visit NeuroMetrix.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
About ReedSmith:
Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. Their long-standing relationships and international outlook make them the go-to partner for speedy resolution of complex transactions, disputes and regulatory matters.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
[email protected]
Source: NeuroMetrix, Inc.


SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 



